SCHEMBL17811488

SCHEMBL17811488

C=C(c1ccc([Si](C)(C)C)cc1)c1cccc(C(=C)c2ccc([Si](C)(C)C)cc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
GFER P55789 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34
TUBA3E Q6PEY2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17811499 0.88 ACHE (0.40) ACHEMEN1KMT2AMAPTHTT
SCHEMBL17453273 0.88 MEN1 (0.53) ACHEMEN1KMT2AMAPTHTT
SCHEMBL8346755 0.79 ACHE (0.51) ACHEMEN1KMT2ANR1H2NR1H3
SCHEMBL17811492 0.78 HSD17B14 (0.35) ACHEMEN1KMT2AMAPTHTT
SCHEMBL17811495 0.78 NR1H2 (0.38) ACHEMEN1KMT2AMAPTHTT
SCHEMBL2749446 0.77 MEN1 (0.45) ACHEMEN1KMT2AMAPTHTT
SCHEMBL8343397 0.76 ACHE (0.48) ACHEMEN1KMT2AMAPTHTT
SCHEMBL814654 0.75 MEN1 (0.52) MEN1KMT2AMAPTHTTGFER
Lithium SCHEMBL31099176 0.75 MEN1 (0.44) MEN1KMT2AMAPTHTTGFER
SCHEMBL17811491 0.74 ACHE (0.42) ACHENR1H2NR1H3PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005869-B2 Polymerisation initiators TRINSEO EUROPE GMBH (CH) 2018-06-26 US disclosed
US-20160159956-A1 Polymerisation Initiators TRINSEO EUROPE GMBH (CH) 2016-06-09 US disclosed
US-20160159956-A1 Polymerisation Initiators TRINSEO EUROPE GMBH (CH) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005869-B2 Polymerisation initiators ELOVL5, ELOVL3, ELOVL1 ACHE 3731/4885MEN1 3319/4885KMT2A 2066/4885
US-20160159956-A1 Polymerisation Initiators ELOVL5, ELOVL3, ELOVL1 ACHE 3731/4885MEN1 3319/4885KMT2A 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.